Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)

China · Delayed Price · Currency is CNY

27.06

+0.02 (0.07%)

Feb 24, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceutical Industry Division	2.17B
Pharmaceutical Business Segment	1.29B
Undistributed Amount	4.42M
Medical Services Division	454.52M
Offsets between Segments	-197.31M
Total	3.73B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Mainland China	3.72B						2.19B	1.75B	2.10B	1.78B
Mainland China Growth	-						25.53%	-16.84%	17.95%	10.14%
outside Mainland China	4.55M						5.16M	4.16M	2.69M	3.11M
outside Mainland China Growth	-						24.16%	54.70%	-13.67%	-25.92%
Total	3.73B						2.20B	1.75B	2.10B	1.78B
Total Growth	-						25.53%	-16.75%	17.89%	10.05%

Source: S&P Global Market Intelligence.